Home » Topics » Regulatory

Regulatory
RSS

European Commission grants marketing authorization for Zavesca

Nov. 27, 2002

Expanded indication for EmdogainGel in E.U.

Nov. 27, 2002

Aciphex combination treatment approved for seven-day eradication of H. pylori

Nov. 21, 2002

E.U. approval for Somavert

Nov. 21, 2002

FDA approves SuperGen's NDA to market Mitozytrex

Nov. 20, 2002

First approval for new antipsychotic drug granted by FDA

Nov. 19, 2002

Label change for Biogen's Avonex approved

Nov. 18, 2002

First approval obtained for Cialis

Nov. 15, 2002

Health Canada approves irbesartan for diabetic renal disease

Nov. 13, 2002

Pfizer announces approval of Lipitor for use in children

Nov. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...